Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Sipai Health Technology Co., Ltd. ( (HK:0314) ).
Sipai Health Technology Co., Ltd. announced its annual results for the year ended December 31, 2024, reporting a slight decline in total revenue by 3.1% compared to the previous year. Despite the overall revenue drop, the company experienced growth in its health insurance services and physician research assistance segments, with increases of 18.9% and 9.9% respectively. The specialty pharmacy business, however, saw a decrease of 5.1%. The company reported a normalized net loss reduction of 11.8%, although the IFRS net loss increased by 46.7%. The financial results were audited by Ernst & Young and confirmed by the Board and Audit Committee.
More about Sipai Health Technology Co., Ltd.
Sipai Health Technology Co., Ltd. operates in the healthcare sector, focusing on health insurance services, physician research assistance, and specialty pharmacy business. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -6.97%
Average Trading Volume: 2,418,924
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.83B
See more insights into 0314 stock on TipRanks’ Stock Analysis page.